z-logo
open-access-imgOpen Access
Humanization and Epitope Mapping of Neutralizing Anti-Human Fas Ligand Monoclonal Antibodies: Structural Insights into Fas/Fas Ligand Interaction
Author(s) -
Tsukasa Nisihara,
Yoshitaka Ushio,
Hirohumi Higuchi,
Nobuhiko Kayagaki,
Noriko Yamaguchi,
Kenji Soejima,
Seishi Matsuo,
Hiroaki Maeda,
Yasuyuki Eda,
Ko Okumura,
Hideo Yagita∥
Publication year - 2001
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.167.6.3266
Subject(s) - fas ligand , epitope , monoclonal antibody , ligand (biochemistry) , epitope mapping , trimer , chemistry , microbiology and biotechnology , mutagenesis , antibody , receptor , virology , biology , apoptosis , mutation , immunology , biochemistry , gene , programmed cell death , dimer , organic chemistry
Fas ligand (L)/CD95L, a proapoptotic member of the TNF family, is a potential target for clinical intervention in various diseases. In the present study, we generated a humanized anti-human FasL mAb and characterized the epitopes of neutralizing mAbs by extensive alanine-scanning mutagenesis of human FasL. The predicted molecular model of FasL trimer revealed that the mAbs recognize largely overlapped conformational epitopes that are composed of two clusters, one around the outer tip-forming D-E loop and another near the top of FasL. Both of these sites on FasL are critically involved in the direct interaction with the corresponding receptor, Fas. These results suggest that the mAbs efficiently neutralize FasL cytotoxicity by masking both of these FasL/Fas contact sites.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom